Zepeng Su
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Mesenchymal stem cell research
Papers in
-
- RNA modifications and cancer 3
- Cancer-related gene regulation 3
-
- Immune cells in cancer 3
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- Co-authors
- Wenhui Yu (18 shared papers)Jinteng Li (18 shared papers)Jiajie Lin (20 shared papers)Zhongyu Xie (15 shared papers)Yunshu Che (14 shared papers)Huiyong Shen (14 shared papers)Zheng Guan (13 shared papers)Yanfeng Wu (10 shared papers)
- Journals
- Advanced Science (2 papers)Experimental & Molecular Medicine (2 papers)Acta Pharmaceutica Sinica B (1 paper)Cellular and Molecular Immunology (1 paper)Human Molecular Genetics (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Zepeng Su
19 papers receiving 331 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 78
- Genetics 55
- Rheumatology 45
- Molecular Biology 198
- Orthopedics and Sports Medicine 23
Countries citing papers authored by Zepeng Su
This map shows the geographic impact of Zepeng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zepeng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zepeng Su more than expected).
Fields of papers citing papers by Zepeng Su
This network shows the impact of papers produced by Zepeng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zepeng Su. The network helps show where Zepeng Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Zepeng Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 86 | |
| 2 | 2022 | 59 | |
| 3 | 2023 | 43 | |
| 4 | 2022 | 18 | |
| 5 | 2023 | 17 | |
| 6 | 2017 | 14 | |
| 7 | 2020 | 13 | |
| 8 | 2023 | 12 | |
| 9 | 2025 | 11 | |
| 10 | 2023 | 10 | |
| 11 | 2023 | 9 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2023 | 8 | |
| 15 | 2024 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2026 | 0 |
About Zepeng Su
Zepeng Su is a scholar working on Molecular Biology, Immunology, Genetics, Cancer Research and Epidemiology, having authored 24 papers that have together received 333 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (5 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (3 papers), Cancer-related gene regulation (3 papers), Autophagy in Disease and Therapy (3 papers), Immune cells in cancer (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Cancer Research (78 citations), Genetics (55 citations), Rheumatology (45 citations), Molecular Biology (198 citations) and Orthopedics and Sports Medicine (23 citations). Zepeng Su has collaborated with scholars based in China and United States. Frequent co-authors include Wenhui Yu, Jinteng Li, Jiajie Lin, Zhongyu Xie, Yunshu Che, Huiyong Shen, Zheng Guan, Yanfeng Wu, Peng Wang and Wenjie Liu. Their work appears in journals such as Advanced Science, Experimental & Molecular Medicine, Acta Pharmaceutica Sinica B, Cellular and Molecular Immunology and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.